Renovion

Renovion, founded in 2013, is on a mission to transform the treatment of chronic inflammatory lung diseases. The company is currently developing clinical programs related to its lead therapeutic candidate, ARINA-1. ARINA-1 is an inhaled therapy designed to improve mucus clearance and reduce inflammation in patients diagnosed with chronic lung conditions.